Piper Sandler Maintains Overweight on Glaukos, Lowers Price Target to $165

Benzinga · 4d ago
Piper Sandler analyst Matt O'Brien maintains Glaukos (NYSE:GKOS) with a Overweight and lowers the price target from $180 to $165.